Mental Health Care: Mindful Care (Kearny) is partnering with NeuroKaire to add a blood-draw “brain biology” test to antidepressant prescribing, aiming to reduce trial-and-error for depression. Health Fraud: Federal prosecutors say a New Jersey eye care founder ran an eight-year Medicare scheme involving diagnostic tests that, prosecutors allege, were never reviewed and were unnecessary for surgery decisions. Drug Policy & Access: Arkansas pharmacy regulators voted not to enforce a 2025 law limiting which pharmacies can buy drugs after a federal judge ruled it unconstitutional—part of a broader fight over state drug access rules. Women’s Health & Legal: Johnson & Johnson agreed to a proposed $5.5B settlement covering about 76,000 talc ovarian cancer claims, including many remaining cases consolidated in New Jersey. Clinical Research: Penn and CHOP researchers report new findings on how human kidneys develop in utero, pointing to IGF2 as a key signal for sustaining kidney stem-like cells. Public Health: A new federal audit found many children in foster care were temporarily placed in hotels and other unlicensed settings when states couldn’t find approved options, with older kids and those with complex needs hit hardest. Local Health & Safety: Trenton police leaders tout accreditation improvements, but a CBS investigation reports a recent uptick in officers using force and ongoing civil-rights concerns raised by defense attorneys.